Menu
Careers
Contact
Menu
Home
Company
Introduction
Senior Management Team
Board of Directors
Scientific Advisors
Clinical Research
Overview
FAQs
For Patients
Technology
DfuseRx℠ Product Discovery Technology
Pipeline
Lead Product: INT230-6
Mechanism of Action
Intellectual Property and Patents
Partnerships
News & Events
Press Releases
Events and Presentations
Intensity Therapeutics in the News
Publications, Papers and Posters
Investors
Menu
Home
Company
Introduction
Senior Management Team
Board of Directors
Scientific Advisors
Clinical Research
Overview
FAQs
For Patients
Technology
DfuseRx℠ Product Discovery Technology
Pipeline
Lead Product: INT230-6
Mechanism of Action
Intellectual Property and Patents
Partnerships
News & Events
Press Releases
Events and Presentations
Intensity Therapeutics in the News
Publications, Papers and Posters
Investors
Careers
Contact
Financials
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events & Presentations
Email Alerts
Company Info
Overview
Management Team
Contacts
FAQ
Financials
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Latest Financial Results
Q3 2024
Quarter Ended Sep 30, 2024
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
Latest 10-K
View HTML
View PDF
Financials
View the latest financials
Balance Sheet
Income Statement
Cash Flow
Email Alerts
Contacts
RSS News Feed